Know Cancer

or
forgot password

Quality of Life Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser


N/A
18 Years
N/A
Open (Enrolling)
Both
Breast Cancer, Radiation-Induced Telangiectasias

Thank you

Trial Information

Quality of Life Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser


Inclusion Criteria:



- Locally advanced breast cancer patients treated with surgery and adjuvant radiation

- Telangiectasias in the radiation field of the treated breast

- Patients 18 years or older

Exclusion Criteria:

- Non English speaking

- Current oral steroid use or receiving daily therapeutic anticoagulation (e.g.
Coumadin, Lovenox)

- Pregnancy or lactation

- Previous laser treatment of telangiectasias

- Presence of a sun tan in the area

- Fitzpatrick skin types V, VI

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

evaluate quality-of-life (QoL)

Outcome Description:

in breast cancer survivors with chronic radiation-induced telangiectasias who are undergoing pulsed dye laser treatment. To assess quality of life in relation to the radiation-induced telangiectasias, two pre-existing validated scales will be utilized. The Skindex-16 and BREAST-Q are scales that have been validated to assess quality of life.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Erica Lee, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

13-013

NCT ID:

NCT01803516

Start Date:

February 2013

Completion Date:

February 2015

Related Keywords:

  • Breast Cancer
  • Radiation-Induced Telangiectasias
  • Quality of Life
  • Assessments
  • Radiation
  • Telangiectasias
  • 13-013
  • Breast Neoplasms
  • Telangiectasis

Name

Location

Memorial Sloan-Kettering Cancer Center New York, New York  10021